Psychotherapy and the Prevention of Relapse in Schizophrenia

Despite major advances in psychopharmacology, schizophrenia remains one of the most disabling conditions in psychiatry. Antipsychotic medications are the cornerstone of treatment and remain the most effective intervention for reducing psychotic symptoms and preventing relapse.¹ Yet medication alone is often insufficient. Many patients continue to experience residual symptoms, recurrent hospitalizations, social isolation, demoralization, and difficulty making sense of their experiences even when pharmacologic treatment is optimized. Increasingly, there is recognition that psychotherapy, when integrated thoughtfully with biological treatment, can play an important role in relapse prevention and long-term recovery.^2-4

Historically, psychotherapy occupied a central place in the treatment of schizophrenia prior to the introduction of chlorpromazine and other neuroleptics in the 1950s. Psychoanalytic and interpersonal clinicians such as Harry Stack Sullivan, Frieda Fromm-Reichmann, Silvano Arieti, Harold Searles, and Otto Will emphasized the importance of human connection, empathy, and therapeutic understanding in work with psychotic patients.^5,6 Many of these early clinicians viewed schizophrenia as deeply understandable psychologically and often conceptualized family dynamics, particularly maternal relationships, as causative. The notorious schizophrenogenic mother hypothesis emerged from this tradition and contributed to unjust blame directed toward families.

Modern psychiatry has rightly moved away from these theories. Contemporary evidence strongly supports schizophrenia as a predominantly biological disorder with substantial genetic and neurodevelopmental contributions. Twin and family studies consistently demonstrate high heritability, and advances in neuroscience continue to implicate abnormalities in dopamine, glutamate, and neural connectivity.⁷ Although environmental stressors and adverse experiences may influence course and expression, simplistic psychogenic explanations are no longer tenable.

At the same time, abandoning etiologically speculative psychological theories does not require abandoning psychotherapy. One of the risks in contemporary psychiatry is the assumption that because a particular mental illness is biologically based, psychological treatment is therefore irrelevant. This conclusion does not follow. Many areas of medicine employ psychosocial interventions for biologically mediated illnesses. Diabetes, cardiovascular disease, and chronic pain all benefit from education, support, behavioral interventions, and therapeutic alliance despite having biological underpinnings.

Utilizing Psychotherapy in Schizophrenia

An etiologically neutral approach to psychotherapy for schizophrenia does not presume that psychotic symptoms are caused by unconscious conflicts, dysfunctional parenting, or symbolic meanings hidden beneath every delusion. Rather, it acknowledges that the causes of schizophrenia are complex and incompletely understood while remaining open to the fact that psychotic experiences often carry personal meaning and psychological significance for the individual patient. This distinction is important clinically. Patients frequently wish to understand their experiences, fears, voices, and beliefs in ways that help restore coherence to their lives.

Supportive psychotherapy likely remains the most broadly applicable psychotherapeutic approach for schizophrenia. The goals are pragmatic and stabilizing: strengthening reality testing, improving medication adherence, reducing stress, fostering adaptive coping, supporting interpersonal functioning, and helping patients recognize early warning signs of relapse. The therapeutic relationship itself may serve as a stabilizing influence, particularly for individuals whose illness is associated with profound social withdrawal, mistrust, or fragmentation of self-experience.

Basic empathy is especially important in this regard. Patients with schizophrenia often describe feeling profoundly misunderstood or feared by others. An empathic therapeutic stance may reduce shame, improve engagement with treatment, and strengthen alliance with clinicians. Importantly, empathic understanding has relevance not only in formal psychotherapy but across all treatment settings, including inpatient units, emergency departments, and outpatient clinics.⁸ Simply helping patients feel understood may reduce alienation and hopelessness, both of which can contribute to decompensation and relapse.

Psychotherapy may also help patients develop greater reflective capacity regarding their symptoms. Some individuals gradually learn to recognize subtle signs of relapse, such as increased suspiciousness, social withdrawal, sleep disturbance, or heightened emotional sensitivity. Identifying these experiences early can facilitate intervention before a full psychotic relapse occurs.

Psychosocial Interventions

Systematic reviews and meta-analyses suggest that several psychosocial interventions, particularly family interventions, psychoeducation, and certain cognitive behavioral approaches, are associated with meaningful reductions in relapse and rehospitalization rates in schizophrenia.⁹ Family-based interventions, in particular, have demonstrated reductions in relapse rates of approximately 20% in some studies,¹⁰ highlighting the importance of social and interpersonal support in long-term stabilization. Patients who understand the nature of their illness, the importance of medication adherence, and the impact of stress and substance use on psychosis often become more active participants in their own care. Recovery-oriented models increasingly emphasize not only symptom reduction but also quality of life, social functioning, autonomy, and meaningful participation in community life.

CBTp

Cognitive behavioral therapy for psychosis (CBTp) represents one approach that may assist some patients in managing hallucinations, delusions, and associated distress. CBTp generally does not attempt to directly eliminate psychotic experiences; rather, it helps patients examine interpretations of those experiences, reduce catastrophic thinking, and improve coping strategies.¹¹ Even when psychotic symptoms persist, CBTp may help reduce the emotional distress and functional impairment associated with them. The evidence for CBTp is mixed but generally supportive of modest benefit in appropriately selected patients.⁴ Some studies suggest improvements in distress, functioning, and hospitalization rates, though effect sizes are often small and disagreement exists regarding the magnitude of benefit. Nevertheless, CBTp can be a valuable adjunctive treatment, particularly for patients with persistent symptoms despite medication.

Psychodynamic Psychotherapy

Psychodynamic psychotherapy has a long history in the treatment of schizophrenia, dating back to the early-to-mid-20th century and institutions such as Chestnut Lodge and the Menninger Clinic. Classical psychoanalytic approaches that emphasized regression, intensive interpretation, or uncovering presumed childhood causes are generally inappropriate for most patients with active psychosis and may be destabilizing. Yet contemporary psychodynamic approaches are often far more supportive, relational, and flexible than earlier caricatures suggest.⁶ Modern psychodynamic psychotherapy for schizophrenia typically emphasizes emotional attunement, attention to interpersonal experience, strengthening of ego functions, and helping patients make sense of frightening or confusing mental states.

Importantly, psychodynamic psychotherapy need not conflict with biological psychiatry. Silvano Arieti, one of the major psychodynamic thinkers on schizophrenia, argued decades ago for an integrated biological and psychological understanding of the disorder.¹² More recently, psychiatrist Michael Garrett has advanced an integrative model combining psychodynamic understanding with CBT techniques and modern psychiatric treatment.³ Garrett emphasizes collaborative exploration of psychotic experiences while maintaining careful attention to reality testing and medication treatment. His work demonstrates that psychodynamic curiosity about subjective experience can coexist with a medical understanding of schizophrenia.

Humanizing Care

Perhaps the most important contribution of psychotherapy in schizophrenia is not symptom reduction per se but the restoration of personhood. Schizophrenia can be profoundly dehumanizing. Patients are often defined exclusively by symptoms, hospitalizations, or disability. Stigma remains a major barrier to recovery for many individuals with schizophrenia and may contribute to social isolation and diminished self-esteem. Psychotherapy reminds clinicians that behind the hallucinations and delusions is a human being struggling to preserve meaning, dignity, relationships, and identity. The psychoanalyst Otto Will emphasized that effective treatment begins with genuinely knowing the patient as a person rather than merely observing symptoms.¹³ This attitude remains relevant today.

Concluding Thoughts

None of this diminishes the importance of antipsychotic medication. For most patients with schizophrenia, maintenance pharmacotherapy remains essential for relapse prevention. Psychotherapy should not be viewed as an alternative to biological treatment but as an adjunct to it. The false dichotomy between biological and psychological approaches has harmed the field for decades. Patients benefit most when clinicians integrate both perspectives thoughtfully and pragmatically.³

A modern psychotherapy for schizophrenia should therefore be empirically informed, etiologically cautious, biologically grounded, and deeply humane. It should avoid blaming families or making speculative claims about causation while still recognizing that psychotic experiences occur within the context of a person’s life, relationships, and subjective world. Ultimately, effective treatment requires recognizing that patients with schizophrenia are not merely a collection of symptoms but individuals attempting to maintain identity, dignity, and connection despite severe mental illness. In this balanced form, psychotherapy may help reduce relapse not only by improving adherence and coping but also by fostering understanding, connection, and hope.

Dr Ruffalo is an assistant professor of psychiatry at the University of Central Florida College of Medicine in Orlando, where he is director of psychotherapy training in the adult psychiatry residency program. He is also an adjunct assistant professor of psychiatry at Tufts University School of Medicine in Boston, Massachusetts, and on the faculty of The New Jersey Institute for Training in Psychoanalysis in Teaneck, New Jersey.

Ms Ruffalo practices psychotherapy at a private practice in North Wales, Pennsylvania.

References

1. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223.

2. Brus M, Novakovic V, Friedberg A. Psychotherapy for schizophrenia: a review of modalities and their evidence base. Psychodyn Psychiatry. 2012;40(4):609-616.

3. Garrett M. Psychotherapy for Psychosis: Integrating Cognitive-Behavioral and Psychodynamic Treatment. Guilford Press; 2019.

4. Ruffalo ML. The psychotherapy of schizophrenia: a review of the evidence for psychodynamic and nonpsychodynamic treatments. Psychiatry Clin Psychopharmacol. 2023;33(3):222-228.

5. Stone MH. The history of the psychoanalytic treatment of schizophrenia. J Am Acad Psychoanal. 1999;27(4):583-601.

6. Walsh J. Can relational therapy be appropriate for clients with schizophrenia? Practice. 2016;28(4):1-14.

7. Leucht S, Siafis S, McGrath JJ, et al. Schizophrenia. Nat Rev Dis Primers. 2025;11(1):83.

8. Ruffalo ML, Kottapalli M, Anbukkarasu P. Empathy in the care of individuals with schizophrenia: a vital element of treatment. Am J Psychother. 2023;77(1):30-34.

9. Bighelli I, Rodolico A, Pitschel-Walz G, et al. Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence. BMJ Open. 2020;10(1):e035073.

10. Pitschel-Walz G, Leucht S, Bäuml J, et al. The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. Schizophr Bull. 2001;27(1):73-92.

11. Sheffield JM, Brinen AP, Feola B, et al. Understanding cognitive behavioral therapy for psychosis through the predictive coding framework. Biol Psychiatry Glob Open Sci. 2024;4(4):100333.

12. Arieti S. Interpretation of Schizophrenia. 2nd ed. Basic Books; 1974.

13. Will OA. On “caring” in psychotherapy. Psychiatry. 2021;84(1):2-15.